PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

If other companies are unable to replicate Bene's PPS I highly...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    If other companies are unable to replicate Bene's PPS I highly doubt PAR will be able to. From memory, Bene's PPS also goes through a processing step to synthetically modify the compounds, which might explain why it may function differently to other PPS preparations. Let's just say it might be easier (and less expensive) to test a new PPS product in OA than it would be to replicate Bene's product.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.